T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$2.6B |
| 2 |
BNY
Bank of New York Mellon
BNY
|
+$1.1B |
| 3 |
Elevance Health
ELV
|
+$903M |
| 4 |
DD
Du Pont De Nemours E I
DD
|
+$873M |
| 5 |
Medtronic
MDT
|
+$868M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$3.89B |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$1.06B |
| 3 |
CFN
CAREFUSION CORPORATION
CFN
|
+$946M |
| 4 |
Aptiv
APTV
|
+$886M |
| 5 |
KSU
Kansas City Southern
KSU
|
+$662M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.57% |
| 2 | Consumer Discretionary | 13.93% |
| 3 | Financials | 13.16% |
| 4 | Industrials | 12.02% |
| 5 | Technology | 10.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ASCMA
1276
DELISTED
Ascent Capital Group, Inc. Series A
ASCMA
| $12.2M | ﹤0.01% |
306,567
-382,571
| -56% | -$17M |
|
|
CJES
1277
DELISTED
C&J ENERGY SVCS LTD
CJES
| $12.2M | ﹤0.01% |
1,095,570
-254,530
| -19% | -$3.04M |
|
|
KW
1278
DELISTED
Kennedy-Wilson Holdings
KW
| $12.2M | ﹤0.01% |
466,243
+19,900
| +4% | +$527K |
|
|
ADT
1279
DELISTED
ADT Corp
ADT
| $12.2M | ﹤0.01% |
293,331
-5,742
| -2% | -$215K |
|
|
PVA
1280
DELISTED
PENN VIRGINIA CORP
PVA
| $12.2M | ﹤0.01% |
+1,878,420
| New | +$12M |
|
|
FTR
1281
DELISTED
Frontier Communications Corp.
FTR
| $12.1M | ﹤0.01% |
114,683
-640
| -0.6% | -$70.8K |
|
1282
Ribbon Communications
RBBN
$372M
| $12.1M | ﹤0.01% |
1,535,478
+162,980
| +12% | +$2.68M |
|
|
OXFD
1283
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $12.1M | ﹤0.01% |
858,500
+8,600
| +1% | +$117K |
|
1284
MaxLinear
MXL
$7.38B
| $12M | ﹤0.01% |
1,481,830
+6,700
| +0.5% | +$55.1K |
|
1285
NETSCOUT
NTCT
$2.87B
| $12M | ﹤0.01% |
273,400
-4,800
| -2% | -$186K |
|
|
JMP
1286
DELISTED
JMP Group LLC
JMP
| $12M | ﹤0.01% |
1,427,912
-17,500
| -1% | -$135K |
|
|
DYN
1287
DELISTED
Dynegy, Inc.
DYN
| $11.9M | ﹤0.01% |
377,609
-216,351
| -36% | -$6.18M |
|
1288
Insulet
PODD
$10.2B
| $11.8M | ﹤0.01% |
353,541
+165,660
| +88% | +$5.59M |
|
|
PPLI
1289
People Inc
PPLI
$3.01B
| $11.8M | ﹤0.01% |
975,755
+43,471
| +5% | +$503K |
|
|
SLCA
1290
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $11.7M | ﹤0.01% |
329,214
+302,700
| +1,142% | +$8.84M |
|
1291
Stewart Information Services
STC
$2.07B
| $11.7M | ﹤0.01% |
287,523
+280,143
| +3,796% | +$10.5M |
|
1292
Essent Group
ESNT
$6.23B
| $11.6M | ﹤0.01% |
486,270
+6,880
| +1% | +$165K |
|
1293
Core Laboratories
CLB
$584M
| $11.6M | ﹤0.01% |
110,905
-20,048
| -15% | -$2.14M |
|
1294
Williams-Sonoma
WSM
$28.6B
| $11.6M | ﹤0.01% |
290,400
+2,000
| +0.7% | +$79.3K |
|
|
COHR
1295
DELISTED
Coherent Inc
COHR
| $11.5M | ﹤0.01% |
177,700
+3,750
| +2% | +$234K |
|
|
ESPR
1296
DELISTED
Esperion Therapeutics
ESPR
| $11.5M | ﹤0.01% |
+124,644
| New | +$8.04M |
|
1297
Leggett & Platt
LEG
$1.33B
| $11.5M | ﹤0.01% |
249,946
+38,200
| +18% | +$1.7M |
|
1298
Globe Life
GL
$14.1B
| $11.5M | ﹤0.01% |
209,716
-15,510
| -7% | -$825K |
|
|
NXEO
1299
DELISTED
Nexeo Solutions, Inc. Common Stock
NXEO
| $11.5M | ﹤0.01% |
1,150,220
-313,180
| -21% | -$3.15M |
|
|
SNI
1300
DELISTED
Scripps Networks Interactive, Inc Common Class A
SNI
| $11.4M | ﹤0.01% |
166,060
+3,480
| +2% | +$253K |
|
Similar funds
T. Rowe Price Associates's Q1 2015 Portfolio in Review
As of Q1 2015, T. Rowe Price Associates held 2,630 positions worth $484B, up 2.8% from $471B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
T. Rowe Price Associates's Q1 2015 filing shows 93 new, 1,078 increased, 887 reduced and 93 closed positions. Its largest new stake was ACTAVIS PLC Pfd Conv Ser A (Irl): 516,600 shares worth $532M. The largest sale was Allergan Inc, an estimated $3.89B.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q1 2015 buy was ACTAVIS PLC Pfd Conv Ser A (Irl): 516,600 shares worth $532M.
- T. Rowe Price Associates added most to Allergan plc in Q1 2015, an estimated $2.6B increase.
- T. Rowe Price Associates's biggest Q1 2015 reduction was Aptiv, cutting an estimated $886M.
- T. Rowe Price Associates fully exited Allergan Inc in Q1 2015, selling an estimated $3.89B.
- T. Rowe Price Associates's ten largest holdings make up 13% of its $484B portfolio in Q1 2015.
- T. Rowe Price Associates opened 93 new positions and closed 93 in Q1 2015.
- T. Rowe Price Associates's portfolio value rose 2.8% quarter-over-quarter to $484B.
Based on T. Rowe Price Associates's 13F filing for Q1 2015, filed 15 May 2015.